首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Sufentanil-2-Hydroxypropyl-β-Cyclodextrin Inclusion Complex For Pain Treatment: Characterization, Toxicity and Pharmacological Evaluation
【24h】

Sufentanil-2-Hydroxypropyl-β-Cyclodextrin Inclusion Complex For Pain Treatment: Characterization, Toxicity and Pharmacological Evaluation

机译:None

获取原文

摘要

This study aimed to characterize and to investigate the hemolytic effects, the miotoxicity and the analgesic properties of the sufentanil:2-hydroxypropyl-β- cyclodextrin inclusion complex (SUF:HP-β-CD). Physico-chemical characterization indicated the formation of a stable complex. In vitro and in vivo assays showed that the SUF:HP-β-CD presented muscle compatibility, less hemolytic effects and increased the duration of analgesia, being an effective novel formulation to enhance the pharmacological effects of sufentanil.
机译:本研究旨在表征和研究Sufentanil:2-羟丙基-β-环糊精包合物(SUF:HP-β-CD)的溶血性效果,瞳孔毒性和镇痛性能。物理化学表征表明形成稳定的复合物。体外和体内测定表明,SUF:HP-β-CD呈现肌肉相容性,较少的溶血作用,增加镇痛的持续时间,是增强Sufentanil的药理学作用的有效新型制剂。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号